Provided By PR Newswire
Last update: Nov 20, 2025
NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:PETS (11/21/2025, 12:10:50 PM)
1.63
+0.02 (+1.24%)
Find more stocks in the Stock Screener


